AI-based Clinical Trial Solutions For Patient Matching Market
Request Sample     Request discount  
Request Sample  
Request Discount  
Request Customization  

Global AI-based Clinical Trial Solutions for Patient Matching Market Size, Share & Trends Analysis Report By Therapeutic Application, By Solution Type, By End-use, By Region, And Segment Forecasts, 2024 - 2031

  • Published Date : 2024-09-20
  • Pages : 100
  • Report Id : 40463
  • Categories : Healthcare

This report describes the global market size of AI-based Clinical Trial Solutions for Patient Matching Market from 2019 to 2022 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2031 and its expected to grow with a CAGR of 26.9% from 2024 to 2031.

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for AI-based Clinical Trial Solutions for Patient Matching Market estimated at US $ 228.6 million in the year 2022, is projected to reach a revised size of US $ 2,789.37 million by 2031, growing at a CAGR of 26.9% during the forecast period 2024-2031.

The AI-based Clinical Trial Solutions for Patient Matching Market refers to the sector focused on using artificial intelligence (AI) technologies to enhance the process of matching patients with suitable clinical trials. This market involves the development and deployment of AI-driven platforms and tools designed to streamline and improve the recruitment of patients for clinical studies.


For geography segment, regional supply, demand, major players, price is presented from 2019 to 2031. This report cover following regions:
North America
Asia-Pacific
Europe
Middle East and Africa
South America


The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For competitor segment, the report include global key players of AI-based Clinical Trial Solutions for Patient Matching Market as well as some small players. The information for each competitor include:
Company Profile
Main Business Information
SWOT Analysis
Sales Volume, Revenue, Price and Gross Margin
Market Share

By Solution Type
Software Solutions
Standalone Software
Integrated Software
Service-Based Solutions
Managed Services
Managed Services

The AI-based Clinical Trial Solutions for Patient Matching Market is segmented by solution type into software solutions and service-based solutions. Software solutions include standalone software, which operates independently to provide specific functionalities for patient matching, and integrated software, which combines multiple features and systems to offer a comprehensive platform for clinical trial management. Service-based solutions encompass managed services, where external providers handle the management and execution of patient matching processes, and consulting services, which offer expert advice and support for optimizing patient recruitment strategies and AI implementation. Each solution type plays a crucial role in enhancing the efficiency and accuracy of patient matching in clinical trials.

By Therapeutic Application
Oncology
Cardiovascular Diseases
Metabolic Diseases
Neurological Diseases or Conditions
Infectious Diseases
Others

The AI-based Clinical Trial Solutions for Patient Matching Market is segmented by therapeutic application, addressing various medical fields. Oncology involves matching patients with trials for cancer treatments, focusing on personalized therapies. Cardiovascular diseases include trials for heart conditions and vascular disorders, aiming to improve treatment outcomes. Metabolic diseases cover trials for conditions like diabetes and obesity, targeting metabolic dysfunctions. Neurological diseases or conditions focus on trials for neurological disorders such as Alzheimers and Parkinsons. Infectious diseases involve trials for combating infections and developing vaccines. The Other category encompasses additional therapeutic areas, addressing diverse health issues and expanding the scope of clinical research.


By End-Use
Pharmaceutical Companies
Academia
Academic Medical Centers & Research Institutes
Others

The AI-based Clinical Trial Solutions for Patient Matching Market is segmented by end-use, including pharmaceutical companies, academia, academic medical centers and research institutes, and others. Pharmaceutical companies use AI solutions to streamline patient recruitment for drug development and clinical trials, enhancing efficiency and accuracy. Academia involves universities and educational institutions utilizing AI to support research and advance clinical study methodologies. Academic medical centers and research institutes focus on integrating AI for both clinical and research purposes, improving trial design and participant matching. The others category includes various organizations and entities involved in clinical trials, such as contract research organizations (CROs) and governmental health agencies, that also benefit from AI-driven patient matching solutions.





Company-
Unlearn.AI, Inc.
Antidote Technologies, Inc.
Deep6.ai
Mendel.ai
Aris Global
Deep Lens AI
AmerisourceBergen Corporation
Koneksa
Microsoft Corporation
GNS Healthcare

Please ask for sample pages for full companies list

Base Year: 2023
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2031

Any special requirements about this report, please let us know and we can provide custom report.


TABLE OF CONTENTS

Market Taxonomy
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis and Recommendations
1.3. RA Analysis and Recommendations
2. Market Introduction
2.1. Market Definition
3. Market Background
3.1. Parent/Associated Market Overview
3.1.1.AI - based Clinical Trial Solutions for Patient Matching Market Outlook
3.1.2.AI - based Clinical Trial Solutions for Patient Matching Market Overview
3.2. Effect of Covid - 19 Impact
3.3. Macro - Economic Overview
3.3.1. GDP Growth
3.3.2. Retail Industry Growth
3.4. Pricing Analysis
3.5. Challenges related to adoption of AI - based Clinical Trial Solutions for Patient Matching Market
3.6. Regulations of AI - based Clinical Trial Solutions for Patient Matching Market
3.7. Forecast Factors: Relevance and Impact
3.8. Market Dynamics
3.8.1. Drivers
3.8.2. Restraints
3.8.3. Opportunity
3.8.4. Trends
3.8.5. SWOT Analysis
4. Market Forecast
4.1. Market Value Projections
4.2. Market Size Projections
4.3. Y - o - Y Projections
4.4. Absolute Opportunity Analysis
5. Global AI - based Clinical Trial Solutions for Patient Matching Market Value Chain Analysis
5.1.AI - based Clinical Trial Solutions for Patient Matching Market Value Chain
5.1.1. List of Raw Material Suppliers
5.1.2. List of AI - based Clinical Trial Solutions for Patient Matching Market Manufacturer
5.1.3. List of Segment
6. Global AI - based Clinical Trial Solutions for Patient Matching Market Analysis Age Group
6.1. Introduction
6.1.1. Market Value Share Analysis By Solution Type
6.1.2. Y - o - Y Growth Analysis By Solution Type
6.2. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Solution Type
6.3. Market Attractiveness Analysis Age Group
7. GlobalAI - based Clinical Trial Solutions for Patient Matching Market Analysis By Therapeutic Application
7.1. Introduction
7.1.1. Market Value Share Analysis By Therapeutic Application
7.1.2. Y - o - Y Growth Analysis By Therapeutic Application
7.2. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Therapeutic Application
7.3. Market Attractiveness Analysis By Therapeutic Application
8. Market Structure Analysis
8.1. Market Analysis by Tier of Companies
8.1.1. By Large, Medium, and Small
8.2. Market Concentration
8.2.1. By Top 5 and by Top 10
8.3. Type ion Capacity Share Analysis
8.3.1. By Large, Medium, and Small
8.3.2. By Top 5 and Top 10
8.4. Technology Roadmap
9. Competition Analysis
9.1. Competition Dashboard
9.2. Company Profiles (15 Companies)
9.2.1.Unlearn.AI, Inc.
9.2.1.1. Overview
9.2.1.2. Type Portfolio
9.2.1.3. Financial Overview
9.2.2. Antidote Technologies, Inc.
9.2.2.1. Overview
9.2.2.2. Type Portfolio
9.2.2.3. Financial Overview
9.2.3. Deep6.ai
9.2.3.1. Overview
9.2.3.2. Type Portfolio
9.2.3.3. Financial Overview
9.2.4.Aris Global
9.2.4.1. Overview
9.2.4.2. Type Portfolio
9.2.4.3. Financial Overview
9.2.5. Deep Lens AI
9.2.5.1. Overview
9.2.5.2. Type Portfolio
9.2.5.3. Financial Overview
9.2.6.AmerisourceBergen Corporation
9.2.6.1. Overview
9.2.6.2. Type Portfolio
9.2.6.3. Financial Overview
9.2.7.Koneksa
9.2.7.1. Overview
9.2.7.2. Type Portfolio
9.2.7.3. Financial Overview
9.2.8.Microsoft Corporation
9.2.8.1. Overview
9.2.8.2. Type Portfolio
9.2.8.3. Financial Overview
9.2.9.GNS Healthcare
9.2.9.1. Overview
9.2.9.2. Type Portfolio
9.2.9.3. Financial Overview
9.2.10. Company 10
9.2.10.1. Overview
9.2.10.2. Type Portfolio
9.2.10.3. Financial Overview
9.2.11. COMPANY 11
9.2.11.1. Overview
9.2.11.2. Type Portfolio
9.2.11.3. Financial Overview
9.2.12. COMPANY12
9.2.12.1. Overview
9.2.12.2. Type Portfolio
9.2.12.3. Financial Overview
9.2.13. COMPANY13
9.2.13.1. Overview
9.2.13.2. Type Portfolio
9.2.13.3. Financial Overview
9.2.14. COMPANY14
9.2.14.1. Overview
9.2.14.2. Type Portfolio
9.2.14.3. Financial Overview
9.2.15. COMPANY15
9.2.15.1. Overview
9.2.15.2. Type Portfolio
9.2.15.3. Financial Overview
10. Global AI - based Clinical Trial Solutions for Patient Matching Market Analysis By Region
10.1. Introduction
10.1.1. Market Value Share Analysis By Region
10.1.2. Y - o - Y Growth Analysis By Region
10.2. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Region
10.2.1. North America
10.2.2. Middle East and Africa
10.2.3. South America
10.2.4. Asia - Pacific
10.2.5. Others
10.3. Current Market Size (USD Mn) Forecast 2023 - 2030 By Region
10.3.1. North America
10.3.2. Middle East and Africa
10.3.3. South America
10.3.4. Asia - Pacific
10.3.5. Others
10.4. Market Attractiveness Analysis By Region
11. North America AI - based Clinical Trial Solutions for Patient Matching Market Analysis
11.1. Introduction
11.2. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Country
11.2.1. U.S.
11.2.2. Canada
11.2.3. Mexico
11.2.4. Rest of North America
11.3. Current Market Size (USD Mn) Forecast 2023 - 2030 By Country
11.3.1. U.S.
11.3.2. Canada
11.3.3. Mexico
11.3.4. Rest of North America
11.4. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Solution Type
11.5. Current Market Size (USD Mn) Forecast 2023 - 2030 By Solution Type
11.6. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Therapeutic Application
11.7. Current Market Size (USD Mn) Forecast 2023 - 2030 By Therapeutic Application
12. South America AI - based Clinical Trial Solutions for Patient Matching Market Analysis
12.1. Introduction
12.2. Regional Pricing Analysis
12.3. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Country
12.3.1. Brazil
12.3.2. Argentina
12.3.3. Rest of South America
12.4. Current Market Size (USD Mn) Forecast 2023 - 2030 By Country
12.4.1. Brazil
12.4.2. Argentina
12.4.3. Rest of South America
12.5. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Solution Type
12.6. Current Market Size (USD Mn) Forecast 2023 - 2030 By Solution Type
12.7. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Therapeutic Application
12.8. Current Market Size (USD Mn) Forecast 2023 - 2030 By Therapeutic Application
13. Europe AI - based Clinical Trial Solutions for Patient Matching Market Analysis
13.1. Introduction
13.2. Regional Pricing Analysis
13.3. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Country
13.3.1. Germany
13.3.2. Italy
13.3.3. France
13.3.4. Spain
13.3.5. U.K.
13.3.6. Rest of Europe
13.4. Current Market Size (USD Mn) Forecast 2023 - 2030 By Country
13.4.1. Germany
13.4.2. Italy
13.4.3. France
13.4.4. Spain
13.4.5. U.K.
13.4.6. Rest of Europe
13.5. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Solution Type
13.6. Current Market Size (USD Mn) Forecast 2023 - 2030 By Solution Type
13.7. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Therapeutic Application
13.8. Current Market Size (USD Mn) Forecast 2023 - 2030 By Therapeutic Application
14. Middle East and Africa AI - based Clinical Trial Solutions for Patient Matching Market Analysis
14.1. Introduction
14.2. Regional Pricing Analysis
14.3. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Country
14.3.1. Saudi Arabia
14.3.2. U.A.E.
14.3.3. South Africa
14.3.4. Turkey
14.3.5. Rest of Middle East and Africa
14.4. Current Market Size (USD Mn) Forecast 2023 - 2030 By Country
14.4.1. Saudi Arabia
14.4.2. U.A.E.
14.4.3. South Africa
14.4.4. Turkey
14.4.5. Rest of Middle East and Africa
15. Asia - Pacific AI - based Clinical Trial Solutions for Patient Matching Market Analysis
15.1. Introduction
15.2. Regional Pricing Analysis
15.3. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Country
15.3.1. China
15.3.2. India
15.3.3. Japan
15.3.4. South Korea
15.3.5. Singapore
15.3.6. Australia and New Zealand
15.3.7. Rest of Asia - Pacific
15.4. Current Market Size (USD Mn) Forecast 2023 - 2030 By Country
15.4.1. China
15.4.2. India
15.4.3. Japan
15.4.4. South Korea
15.4.5. Singapore
15.4.6. Australia and New Zealand
15.4.7. Rest of Asia - Pacific
i. Research Methodology
ii. Assumptions & Acronyms


LIST OF FIGURES

Figure 01: Global AI - based Clinical Trial Solutions for Patient Matching Market, BPS Analysis,By Solution Type, 2018(H), 2023(E) & 2030(F)
Figure 02: Global AI - based Clinical Trial Solutions for Patient Matching Market, Y - O - Y Growth,By Solution Type, 2020(A) - 2030(F)
Figure 03: Global AI - based Clinical Trial Solutions for Patient Matching Market Attractiveness Analysis,By Solution Type (2020)
Figure 04: Global AI - based Clinical Trial Solutions for Patient Matching Market, BPS Analysis, By Therapeutic Application, 2018(H), 2023(E) & 2030(F)
Figure 05: Global AI - based Clinical Trial Solutions for Patient Matching Market, Y - O - Y Growth, By Therapeutic Application, 2018(H) - 2030(F)
Figure 06: Global AI - based Clinical Trial Solutions for Patient Matching Market Attractiveness Analysis, By Therapeutic Application
Figure 07: Global AI - based Clinical Trial Solutions for Patient Matching Market, Value Analysis,By Solution Type, 2018(H) - 2030(F)
Figure 08: Global AI - based Clinical Trial Solutions for Patient Matching Market, Value Analysis, by Material , 2018(H) - 2030(F)
Figure 09: Global AI - based Clinical Trial Solutions for Patient Matching Market, BPS Analysis, by Region, 2018(H), 2023(E) & 2030(F)
Figure 10: Global AI - based Clinical Trial Solutions for Patient Matching Market, Y - O - Y Growth, by Region, 2018(H) - 2030(F)
Figure 11: Global AI - based Clinical Trial Solutions for Patient Matching Market Attractiveness Analysis, by Region
Figure 12: North America AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn Forecast, 2018 2022
Figure 13: North America AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn Forecast, 2023 2030
Figure 14: South America AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, 2018 2022
Figure 15: South America AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, 2023 2030
Figure 16: Europe AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, 2018 2022
Figure 17: Europe AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, 2023 2030
Figure 18: Middle East and Africa AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, 2018 2022

LIST OF TABLES

Table 01: Global AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, By Solution Type, 2018(H) 2030(F)
Table 02: Global AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, By Therapeutic Application, 2018(H) 2030(F)
Table 03: Global AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, By Country, 2018(H) 2030(F)
Table 04: North America AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, by Country, 2018(H) 2030(F)
Table 05: North America AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast,By Solution Type, 2018(H) 2030(F)
Table 06: North America AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, By Therapeutic Application, 2018(H) 2030(F)
Table 07: South America AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, By Country, 2018(H) 2030(F)
Table 08: South America AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast,By Solution Type, 2018(H) 2030(F)
Table 09: South America AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, By Therapeutic Application, 2018(H) 2030(F)
Table 10: Europe AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) and Forecast, by Country, 2018(H) 2030(F)
Table 11: Europe AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, By Solution Type, 2018(H) 2030(F)
Table 12: Europe AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, By Therapeutic Application EndUser, 2018(H) 2030(F)
Table 13: Middle East and Africa AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, By Country, 2018(H) 2030(F)
Table 14: Middle East and Africa AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, By Solution Type, 2018(H) 2030(F)
Table 15: Middle East and Africa AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, By Therapeutic Application, 2018(H) 2030(F)
Table 16: Asia - Pacific AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, by Country, 2018(H) 2030(F)
Table 17: Asia - Pacific AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, By Solution Type, 2018(H) 2030(F)
Table 18: Asia - Pacific AI - based Clinical Trial Solutions for Patient Matching Market Value (USD Mn) Forecast, By Therapeutic Application, 2018(H) 2030(F

Immediate acquisition
Your strategic edge begins with Stats and Research
Single User License
$3490
It allows one person, the buyer, to have sole right and access to the purchased report. Further distribution of product is strictly prohibited.
Multi User License
$5240
It allows the purchased product to be shared among 1-5 employees of your organization within same geographical location.
Enterprise User License
$6990
It allows the purchased product to be shared among all employees of your organisation irrespective of their geographical location.
Services
On Demand Reports Subscription Plans Consulting Services ESG Solutions
  View All Healthcare Reports

Global Cellular Products Market

Global Cellular Products Market

Global Blue Light Therapy Device Market

Global Blue Light Therapy Device Market

Global Artificial Intelligence Based Blood Test Market

Global Artificial Intelligence Based Blood Test Market

Global Digital Pills Market

Global Digital Pills Market

Global POC Ultrasound Market

Global POC Ultrasound Market

Global Needle-Free Blood Testing Market

Global Needle-Free Blood Testing Market

Global Medical Tourism Market

Global Medical Tourism Market

Gummy Supplements Market

Gummy Supplements Market

Software As a Medical Device (SaMD) Market

Software As a Medical Device (SaMD) Market

Canada Consumer Healthcare Market

Canada Consumer Healthcare Market

Stats And Research ™ Copyright © 2025 .